Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Update

25 Apr 2017 07:00

RNS Number : 1875D
Imaginatik PLC
25 April 2017
 

25 April 2017

 

Imaginatik plc

("Imaginatik" or "the Company")

 

Trading Update

 

Imaginatik plc (AIM: IMTK.L), the innovation company, today provides an update on trading for the year ended 31 March 2017.

 

The Company expects to report an adjusted loss after tax of £0.55m, broadly in line with market expectations. The result is stated net of an exceptional foreign exchange loss of £0.23m arising as a result of the strong US dollar over the period (2016: adjusted net loss of £0.8m). Recognised revenues for the year are expected to be flat at approximately £3.9m (2016: £3.9m), with overall bookings amounting to £3.6m* (2016: £4.7m*). Renewals in the period remained steady, with approximately 76% of the renewals by value being converted over the period.

 

A total number of 15 new customers were signed during the year (2016: 9), 9 of which are on annual or multi-year contracts consisting of both technology and consulting, and 6 are on consulting engagements. Out of these new customer wins, 11 were added in the second half of the year as sales momentum started to build. New customers include an international financial services provider, a US based multi-national engineering business, a multi-national pharmaceutical company and a global human resources consulting firm.

 

The Company is also pleased to report that is has entered into several partnership agreements during the second half of the year. The most significant of which is for an initial two year period with a leading provider of end-to-end IT services and solutions for Global 1000 companies ("the Partner"). Imaginatik will provide its technology platform and consultancy services to the Partner directly and to the Partner's customer base as part of a jointly developed innovation offering. As well as receiving subscription revenues and consulting fees for the provision of its technology and consulting services, Imaginatik will also be entitled to receive success-based fees based on the total contract value of the joint offering.

 

The directors continue to carefully monitor the Company's cash position and to consider the options available.

 

*At constant currency

 

Matt Cooper, Non-Executive Chairman of Imaginatik, commented:

 

"This has been of year of good underlying progress for the Group. During the period we have added a further range of new blue chip organisations to our outstanding reference customer base, improved the financial strength of the business by reducing trading losses, and maintained the critical investment in the business to enhance the Company's consultancy and technology offerings.

 

"We are also delighted to announce the significant partnership agreement with a multi-national IT services and solutions provider which leverages both businesses' expertise and skillsets to bring comprehensive innovation technology and services to a broader market. As we previously stated, a focus for the business has been on developing and building relationships with strategic partners to expand the Group's market reach and align with other thought leaders in the space. This partnership agreement is a milestone achievement in line with this strategy and opens up a substantial new potential customer base.

 

"As we enter the new financial year the pipeline of new business opportunities is strong and we look forward to providing a further update at the time of full year results."

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

finnCap Ltd

Tel: 020 7220 0500

Jonny Franklin-Adams/Giles Rolls, corporate finance

Camille Gochez, corporate broking

Alma PR

Tel: 020 8004 4218

Hilary Buchanan

Robyn Fisher

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as Exxon Mobil, Altria, Shell, Goodyear, the Yorkshire Building Society, Caterpillar, AECOM, Novartis and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies. In 2016 Forrester Research found that "Imaginatik has the most comprehensive innovation management solution," providing excellent industry recognition of Imaginatik's full-service innovation offering, combining both technology and consultancy services.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE: IMTK.L) with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGGCUPMPUC
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.